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Abstract: Botulinum neurotoxins (BoNTs) are highly potent poisons produced by seven 
serotypes of Clostridium botulinum. The mechanism of neurotoxin action is a multistep 
process which leads to the cleavage of one of three different SNARE proteins essential for 
synaptic vesicle fusion and transmission of the nerve signals to muscles: synaptobrevin, 
syntaxin, or SNAP-25. In order to understand the precise mechanism of neurotoxin in a 
host, the domain structure of the neurotoxin was analyzed among different serotypes of C. 
botulinum. The results indicate that neurotoxins type A, C, D, E and F contain a coiled-coil 
domain while types B and type G neurotoxin do not. Interestingly, phylogenetic analysis 
based on neurotoxin sequences has further confirmed that serotypes B and G are closely 
related. These results suggest that neurotoxin has multi-domain structure, and coiled-coil 
domain plays an important role in oligomerisation of the neurotoxin. Domain analysis may 
help to identify effective antibodies to treat Botulinum toxin intoxication.  
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1. Introduction  
 
The seven Botulinum neurotoxins (BoNT/A–/G) are bacterial metalloproteases that act in the 
cytosol of cholinergic nerve terminals. They cleave core proteins of the neuroexocytosis apparatus 
causing a long-lasting inhibition of neurotransmitter release [1].BoNTs are extremely toxic proteins of 
150 kDa, and consist of a 100 kDa heavy chain and a 50 kDa light chain linked through a disulfide 
bond [2]. The potency of BoNT/A was determined to be 0.4 × 10
8 i.p. LD50 per mg [1].The discovery 
that BoNTs are Zn
2+-endopeptidases [3] has led to identification of several target proteins, which are 
critical for the docking and fusion of synaptic vesicles to the plasma membrane in the neurotransmitter 
release process.VAMP (Vesicle Associated Membrane Protein), SNAP-25 (synaptosome associated 
protein of 25 kDa) and syntaxin form the SNARE complex during docking of synaptic vesicles to the 
plasma membrane. Different BoNTs proteolytically cleave synaptic proteins. For example, BoNT/B, 
BoNT/G, BoNT/D and BoNT/F cleave VAMP, BoNT/A, BoNT/C and BoNT/E, cleaves SNAP-25 and 
BoNT/C cleave syntaxin as part of their mode of action to block neurotransmitter release [4]. 
Protein-protein interactions play a central role in many cellular functions, and as whole-genome 
data accumulates, computational methods for predicting these interactions become increasingly 
important. Computational methods have proven to be a useful first step for rapid genome-wide 
identification of putative protein structure and function. In the genomic era, one of the most interesting 
and important challenges is to understand protein interactions on a large-scale. The physical 
interactions between protein domains are fundamental to the workings of a cell: in multi-domain 
polypeptide chains, in multi-subunit proteins and in transient complexes between proteins that also 
exist independently. Protein domain interactions are essential to the functioning of individual cells and 
whole organisms by acting in several ways: domain-domain interactions in multi-domain polypeptide 
chains, inter-chain protein interactions in obligate complexes such as multimers or oligomers and in 
transient complexes between proteins that can also exist independently. Therefore, it is not surprising 
that protein interactions have been extensively investigated using various methods.  
The parallel two-stranded α-helical coiled-coil is the most frequently encountered subunit 
oligomerization motif in proteins. The simplicity and regularity of this motif have made it an attractive 
system to explore some of the fundamentals of protein folding and stability and in testing the 
principles of de novo design [5]. Despite its simplicity, it is a highly versatile folding motif; coiled-
coil-containing proteins exhibit a broad range of different functions related to the specific 'design' of 
their coiled-coil domains. The architecture of a particular coiled-coil domain determines its 
oligomerization state, rigidity and ability to function as a molecular recognition system [6].  
In this study, we have examined the protein domains of seven serotypes derived from published 
amino acid sequence of BoNTs serotypes. All BoNT serotypes have common protein domains present 
except BoNT/B and BoNT/G. Our analysis provides evidence that BoNT/B and BoNT/G do not have 
coiled-coil domains and they appeared to be derived from a common ancestor Toxins 2010, 2                             
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2. Results and Discussion  
 
Multiple sequence alignment, domain analysis and phylogenetic analysis 
 
The crystallographic structure of BoNT/A and BoNT/B molecules consists of three structural 
domains matching to three functional domains, namely catalytic, translocation and binding [7]. These 
three domains are arranged in a linear fashion with the translocation domain in the middle. An overlay 
of BoNT/B holotoxin with BoNT/A holotoxin indicates that the translocation domain belt has a 
different position in serotype B. The altered position of the belt in BoNT/B increases exposure of the 
active site relative to BoNT/A holotoxin [8]. The structure of the binding domain is very similar to that 
of the C-fragment of tetanus toxin and the binding domain of BoNT/A [9,10]. In BoNT/B, the 
translocation domain consists of two long helical regions, each 105 Å long, that form coiled coils. 
However, this region does not adopt a helical conformation. The only α-helix in this region is from 
residues 638–645 which is in the middle part of the molecule. BoNT/A translocation domain differs 
from BoNT/B, especially at residues 481–532 that wrap around the catalytic domain, as to keep the 
catalytic domain in position and is known as belt region. The crystallographic data indicate that only 
49% of the residues match in BoNT/A and BoNT/B, indicating that the association of the three 
domains may be different in the two molecules [8], (Figure 1). There is even a lower sequence 
similarity (24%) of the belt region among the seven serotypes and the related clostridial toxins [11,12]. 
 
Figure 1. Comparison of BoNT/A and BoNT/B [8] Stereo view of the C-trace of BoNT/A 
(magenta) superimposed on that of BoNT/B (green). Significant differences in the 
orientations of the C-terminal halves of each binding domain with respect to the 
translocation domain are clearly visible (adopted with permission from   
Swaminathan et al. [8]). 
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The coiled-coil structure is used by nature to stabilize α-helices in proteins. This is possible through 
a very efficient burial of hydrophobic side chains in proteins so that for the most part, they are not 
accessed by polar water molecules. Because of this structure, the helices are quite stable. Many 
structural proteins both inside and outside of cells (keratins, tropomyosin, laminin) have a coiled-coil 
domain. There seem to be basic, but essential, features that are common to coiled-coil peptides. First, 
the overall secondary structure is alpha helical and secondly, the hydrophobic residues are arranged on 
one side of the helices. The typical positioning of the hydrophobic residues in coiled-coils, (i.e., the 
coiled-coil motif), can be often recognized from the primary structure of the protein. One coiled-coil 
motif (4-3 hydrophobic repeats) is a heptads repeat of amino acids from A to G so that A and D are 
hydrophobic and E and G predominantly polar.  
 
Table 1. Coiled coil region in the sequence of botulinum neurotoxins. The amino acid 
number indicates start and end of the residues. 
BoNTs  Position of Coiled coil domain in sequence 
BoNT/A 
BoNT/B 
BoNT/C 
BoNT/D 
BoNT/E 
BoNT/F 
BoNT/G 
717–744 
Absent 
753–773 
750–770 
697–717 
716–736 
Absent 
 
The existence of a coiled-coil structure in close proximity to the translocation domain of BoNT/A, 
however, raises important questions concerning its exact function for blocking the synaptic 
transmission. Except for BoNT/B and BoNT/G, all other serotypes contain coiled-coil regions within 
the N-terminal region of the heavy chain. The C-terminal part of the heavy chain (HC) binds to the 
surface of target nerve cells and the N-terminal part (HN) is involved in the translocation the light 
chain across the membrane [13]. The two sections of heptads repeats (718 to 750 and 755 to 792) in 
BoNT/A have been reported previously [14]. These two coiled-coil regions are predicted to be 
involved in membrane translocation. The existence of oligomeric formation has been reported in 
BoNT/A, E and Tetanus toxin (TeNT) based on native gel electrophoresis and chemical cross-linking 
[15,16]. CD analysis of BoNT/A heavy chain indicates that it undergoes an oligomeric transition with 
the lowering of pH [17]. 
It has been proposed that the belt region, a 54 amino acid segment at the N-terminus of heavy chain 
that wraps around the catalytic domain might act as a chaperone assisting in light chain unfolding, 
channel transit, and refolding [18,19]. BoNT/C also aggregates into dimer or oligomer during channel 
formation [20,21]. The SNAP-25 adopts partial secondary structure upon binding to the light chain in 
the binary complex crystal structure and occupies a similar position as the belt in the holotoxin crystal 
structure of both BoNT/A and BoNT/B [18]. This hypothesis was considered based on the crystal 
structure of BoNT/A and BoNT/B belt region, and structure of SNAP-25 bound to BoNT/A L-chain. 
This observation contradicts our data on the prediction of absent coiled coil domain in BoNT/B, and 
thus its potential role in differential mechanism of translocation in BoNT/A and BoNT/B. BoNT/B has Toxins 2010, 2                             
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been reported to form a dimer [20]. However, the N-terminal part which is involved in the 
translocation,in BoNT/A differs from BoNT/B, especially at residues 481–532 that wrap around the 
catalytic domain, we think that these differences should be taken into account inferring any common 
translocation mechanism of all BoNTs. However, absence of coiled-coil in BoNT/B and BoNT/G 
(Table 1, Figure 2) indicates that either oligomerization may not be involved in the channel formation 
or a different mechanism of channel formation operates in these serotypes.  
 
Figure 2. Alignment of BoNT/A protein sequence with the known protein sequences of 
other serotypes. The yellow highlighted residues are coiled-coil regions 
          651                                                700 
   BoNT/A  IPYIGPALNI GNMLYKDDFV GALIFSGAVI LLEFIPEIAI PVLGTFALVS 
   BoNT/B  VPYIGLALNV GNETAKGNFE NAFEIAGASI LLEFIPELLI PVVGAFLLES 
   BoNT/G  IPYIGPALNV GNETAKENFK NAFEIGGAAI LMEFIPELIV PIVGFFTLES 
   BoNT/E  VPYIGLALNI GNEAQKGNFK DALELLGAGI LLEFEPELLI PTILVFTIKS 
   BoNT/F  VPYVGLALNI IIEAEKGNFE EAFELLGVGI LLEFVPELTI PVILVFTIKS 
   BoNT/D  IPYIGPALNI GNSALRGNFN QAFATAGVAF LLEGFPEFTI PALGVFTFYS 
   BoNT/C  VLWFGKALNI LNTS--NSFV EEYQDSGAIS LISKKDNLRE PNIEIDDISD 
Consensus  !pyiGpALN! gNea.kgnFv eafedsGaii Llefip#lti Pvigvftiss 
           701                                                750 
   BoNT/A  YIA---NKVL TVQTIDNALS KRNEKWDEVY KYIVTNWLAK VNTQIDLIRK 
   BoNT/B  YID---NKNK IIKTIDNALT KRNEKWSDMY GLIVAQWLST VNTQFYTIKE 
   BoNT/G  YVG---NKGH IIMTISNALK KRDQKWTDMY GLIVSQWLST VNTQFYTIKE 
   BoNT/E  FLGSSDNKNK VIKAINNALK ERDEKWKEVY SFIVSNWMTK INTQFNKRKE 
   BoNT/F  YIDSYENKNK AIKAINNSLI EREAKWKEIY SWIVSNWLTR INTQFNKRKE 
   BoNT/D  SIQ---EREK IIKTIENCLE QRVKRWKDSY QWMVSNWLSR ITTQFNHINY 
   BoNT/C  SLLGLSFKDL NNKLYE-IYS KNIVYFKKIY FSFLDQWWTE YYSQYFELIC 
Consensus  sil...nknk iikti#nals kriekwkeiY fwivs#Wltr intQfneike 
           751                                                800 
   BoNT/A  KMKEALENQA EATKAIINYQ YNQYTEEEKN NIN--FNIDD LSS---KLNE 
   BoNT/B  GMYKALNYQA QALEEIIKYR YNIYSEKEKS NIN--IDFND INS---KLNE 
   BoNT/G  RMYNALNNQS QAIEKIIEDQ YNRYSEEDKM NIN--IDFND IDF---KLNQ 
   BoNT/E  QMYQALQNQV NAIKTIIESK YNSYTLEEKN ELTNKYDIKQ IEN---ELNQ 
   BoNT/F  QMYQALQNQV DAIKTAIEYK YNNYTSDEKN RLESEYNINN IEE---ELNK 
   BoNT/D  QMYDSLSYQA DAIKAKIDLE YKKYSGSDKE NIK--SQVEN LKN---SLDV 
   BoNT/C  MAKQSILAQE SLVKQIVQNK FTDLSKASIP PDTLKLIRET TEKTFIDLSN 
Consensus  qmy#allnQa daikai!#yk %ndyseeekn nit..lii#d ien...kLnn  
 
On the contrary, the presence of coiled-coils in a majority of serotypes indicates that 
oligomerization may be playing a functional role beyond translocation within the cell. The neighbor 
joining tree for seven serotypes also indicates that BoNT/B and BoNT/G derived from common 
ancestor (Figure 3). 
Protein receptors for BoNT/B and BoNT/G, (synaptotagmins I and II), bind to a pocket at the tip of 
the C-terminal domain of the C-terminal fragment of the heavy chain. This corresponds to the unique 
second carbohydrate binding site of tetanus neurotoxin, the sialic acid binding site [22,23]. In addition, 
BoNT/B and BoNT/G appears to exhibit lower but same affinity to both synaptotagmins in vitro. 
Similarity calculation based on the C-terminal domain of the C-terminal fragment of the heavy chain 
domain amino acid alignment resulted in 43.8% identity scores between them and every other   
BoNTs [20].  Toxins 2010, 2                             
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Figure 3. Neighbor joining (NJ) tree for 7 sequences BoNT/A to BoNT/G. Numbers 
correspond to percentage of times that a particular topology appeared at a particular node 
in 100 bootstraps. Phylogenetic analysis was performed using CLUSTAL X 1.81 for 
multiple sequence alignment. 
 
 
While there appears to be a similarity in the receptor binding property of BoNT/B and BoNT/G 
which is mediated by C-terminal domain of the C-terminal fragment of the heavy chain, we believe 
that N-terminal part which involve the translocation of the light chain across the membrane could be 
playing a different role in these two serotypes. Note that our computational predictions lack 
biochemical evidences and do not reach yes-or-no decisions based on a threshold value. Rather, it 
yields a set of probabilities that presumably reflect the coiled-coil forming potential in BoNTs 
published sequences. This means that even at high probabilities there will be (and should be) 
sequences that in fact do not form a coiled coil, though they may have the potential to do so in a 
different context. Moreover, the program we used to predict coiled coils cannot predict on   
buried structures.  
Under physiological conditions, the L-chain is believed to separate from the H-chain at the 
endosomal membrane, and the L-chain is only active after reduction of the disulfide bond. To release 
the  L-chain, we believe that it is possible that self oligomerization of the H-chain (probably the   
N-terminal part) causes conformational changes there by releasing the L-chain after a disulfide 
reduction.  
 
3. Experimental Section  
 
3.1. Multiple sequence alignment and domain analysis 
 
The sequence analysis of BoNTs was performed in two steps: (I) protein sequences from seven 
serotypes were obtained from NCBI and analyzed for sequence comparison using the GCG program Toxins 2010, 2                             
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(Accelrys GCG, Formally known as the GCG Wisconsin Package). (ii) multiple sequence alignment 
was performed using CLUSTAL V based on algorithm of Higgins [24]. The domain analysis was 
performed on a Pfam-based PRODOM database using multiple sequence alignments. The Hidden 
Markov Model was used for domain analysis [25,26]. 
 
3.2. Phylogenetic analysis 
 
Phylogenetic analysis of seven serotypes of C. botulinum neurotoxins was performed using 
CLUSTALX 1.81 for multiple sequence alignment and Tree-View for neighbor joining tree 
construction with maximum bootstrapping option [27]. A majority rule consensus tree was generated. 
Values of greater than 80 to 85% were considered strong support and were considered equivalent to  
high-confidence values obtained by bootstrap analysis. 
 
4. Conclusions  
 
These results indicate that neurotoxin has multi-domain structure, and coiled-coil domain plays an 
important role in oligomarization of the neurotoxin. Domain analysis may help to identify effective 
antibodies to treat Botulinum toxin intoxication. A detailed understanding of the architecture, 
catalysis, and recognition properties of these domains will also help to reveal how the toxins achieve 
functional diversity. 
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